Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
A technology for targeting genes and binding proteins, applied in the field of molecular switch systems for gene repression and derepression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0141] suppress human VEGF-A
[0142] To downregulate the expression of human vascular endothelial growth factor A (VEGF-A), a mouse GCL protein encoding 524 amino acids was prepared [Leatherman et al. (2000)] and the targeting sequence 5′-GTGTGG GTG AGT GAG TGT G-3 Recombinant construct of chimeric protein (CPI-vegf) of AZP' (SEQ ID NO: 7). A second construct encoding another chimeric protein (CP2-vegf) was made using the same mouse GCL protein and AZP targeting the sequence 5'-GGG GCT GGG GGCGGT GTC T-3' (SEQ ID NO: 8). The target nucleotide sequence is derived from the promoter of the human VEGF-A gene [Tischer et al. (1991) J. Biol. Chem. 266: 11947-11954]. The AZP has 6 zinc fingers, each with the framework sequence Pro-Tyr-Lys-Cys-Pro-Glu-Cys-Gly-Lys-Ser-Phe-Ser-Z -1 -Ser-Z 2 -Z 3 -Leu-Gln-Z 6 -His-Gln-Arg-Thr-His-Thr-Gly-Glu-Lys- (SEQ ID NO: 3); each frame is linked to the next with no redundant amino acid residues. Table 3 provides the binding specificity (Z -1 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com